Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 1
2011 1
2012 4
2013 4
2014 2
2015 1
2016 6
2017 1
2018 2
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Synthesis and Antifungal Screening of 2-{[1-(5-Alkyl/arylalkylpyrazin-2-yl)ethylidene]hydrazono}-1,3-thiazolidin-4-ones.
Opletalova V, Dolezel J, Kunes J, Buchta V, Vejsova M, Kucerova-Chlupacova M. Opletalova V, et al. Among authors: dolezel j. Molecules. 2016 Nov 23;21(11):1592. doi: 10.3390/molecules21111592. Molecules. 2016. PMID: 27886119 Free PMC article.
Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.
Juracek J, Peltanova B, Dolezel J, Fedorko M, Pacik D, Radova L, Vesela P, Svoboda M, Slaby O, Stanik M. Juracek J, et al. Among authors: dolezel j. J Cell Mol Med. 2018 Mar;22(3):2033-2038. doi: 10.1111/jcmm.13487. Epub 2018 Jan 24. J Cell Mol Med. 2018. PMID: 29363887 Free PMC article.
Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
Juracek J, Stanik M, Vesela P, Radova L, Dolezel J, Svoboda M, Slaby O. Juracek J, et al. Among authors: dolezel j. Urol Oncol. 2019 Mar;37(3):184.e1-184.e7. doi: 10.1016/j.urolonc.2018.10.014. Epub 2018 Nov 13. Urol Oncol. 2019. PMID: 30446443
Thiosemicarbazones and their antimycobacterial effects.
Opletalová V, Doležel J. Opletalová V, et al. Among authors: dolezel j. Ceska Slov Farm. 2013 Apr;62(2):78-83. Ceska Slov Farm. 2013. PMID: 23822572
Comparison of Different Treatment Modalities Outcomes in Clinically Node-positive Bladder Cancer: Analysis of a Population-based Cancer Registry.
Staník M, Poprach A, Zapletalová M, Krejčí D, Macík D, Čapák I, Jarkovský J, Lakomý R, Doležel J. Staník M, et al. Among authors: dolezel j. Clin Genitourin Cancer. 2019 Aug;17(4):e759-e767. doi: 10.1016/j.clgc.2019.04.007. Epub 2019 Apr 16. Clin Genitourin Cancer. 2019. PMID: 31101578
Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma.
Mlcochova H, Machackova T, Rabien A, Radova L, Fabian P, Iliev R, Slaba K, Poprach A, Kilic E, Stanik M, Redova-Lojova M, Svoboda M, Dolezel J, Vyzula R, Jung K, Slaby O. Mlcochova H, et al. Among authors: dolezel j. Sci Rep. 2016 Aug 23;6:31852. doi: 10.1038/srep31852. Sci Rep. 2016. PMID: 27549611 Free PMC article.
Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.
Fedorko M, Juracek J, Stanik M, Svoboda M, Poprach A, Buchler T, Pacik D, Dolezel J, Slaby O. Fedorko M, et al. Among authors: dolezel j. Biochem Med (Zagreb). 2017 Jun 15;27(2):411-417. doi: 10.11613/BM.2017.043. Biochem Med (Zagreb). 2017. PMID: 28694731 Free PMC article.
MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.
Machackova T, Mlcochova H, Stanik M, Dolezel J, Fedorko M, Pacik D, Poprach A, Svoboda M, Slaby O. Machackova T, et al. Among authors: dolezel j. Tumour Biol. 2016 Nov;37(11):14653-14658. doi: 10.1007/s13277-016-5310-9. Epub 2016 Sep 12. Tumour Biol. 2016. PMID: 27619681
Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma.
Fedorko M, Stanik M, Iliev R, Redova-Lojova M, Machackova T, Svoboda M, Pacik D, Dolezel J, Slaby O. Fedorko M, et al. Among authors: dolezel j. Int J Mol Sci. 2015 Sep 29;16(10):23382-9. doi: 10.3390/ijms161023382. Int J Mol Sci. 2015. PMID: 26426010 Free PMC article.
Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients.
Iliev R, Stanik M, Fedorko M, Poprach A, Vychytilova-Faltejskova P, Slaba K, Svoboda M, Fabian P, Pacik D, Dolezel J, Slaby O. Iliev R, et al. Among authors: dolezel j. Onco Targets Ther. 2016 Jan 8;9:217-22. doi: 10.2147/OTT.S91295. eCollection 2016. Onco Targets Ther. 2016. PMID: 26811690 Free PMC article.
22 results
Jump to page
Feedback